Skip to content
DraconiticResearch
Search Sources API
201,642 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1115 Cross-priming by type-1 conventional dendritic cells is critically involved in the efficacy of radiotherapy against cancer

  • Ignacio Melero1
  • Arantza Azpilicueta2
  • Maria Rodriguez-Ruiz2
  • Alvaro Teijeira3
  • David Sancho4
  • Rafael MartÍNez-Monge5
  • Leticia Fernández-Rubio6
  • Raluca Alexandru7
  • Irantzu Serrano-Mendioroz6
  • Eneko Garate-Soraluze8
  • Nekane Soria Picon9
  • Paulo Perez-Dominguez10
3 more authors
  • Carlos lury-Rey9
  • Saioa Arrieta9
  • Carlos E De Andrea11
11 affiliations
  1. 1Clinica Universidad de Navarra and Cima and University of Oxford, Pamplona, Navarra, Spain
  2. 2Aff1 grid.5924.a0000000419370271Immunology and ImmunotherapyCenter for Applied Medical Research Pamplona Spain
  3. 3Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain
  4. 4Immunobiology Laboratory, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Madrid, Spain
  5. 5Departments of Oncology, and
  6. 6Department of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain
  7. 72Clinica Universidad de Navarra, Pamplona, Navarra, Spain
  8. 8Program of Immunology and Immunotherapy, Centro de Investigacion Medica Aplicada, Pamplona, Spain
  9. 9Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Navarra, Spain
  10. 10Clinica Universidad de Navarra, Pamplona, Navarra, Spain
  11. 11University of Navarra, Pamplona, Navarra, Spain
Open at sourcePDFDOICite

Related

  1. Generating and Expanding Conventional Type 1 Dendritic Cells
    Sukriti Sharma, Shandré Pillay, Christian T. Mayer
    European Journal of ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyPMC
  2. Activation of conventional and plasmacytoid dendritic cells and enhancement of anti-viral immune responses by Lactobacillus delbrueckii subsp. bulgaricus OLL1073R-1 and Streptococcus thermophilus OLS3059
    Hiroki Kono, Toshihiro Sashihara
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyImmunologyPLOS
  3. Contrasting Effects of Human, Canine, and Hybrid Adenovirus Vectors on the Phenotypical and Functional Maturation of Human Dendritic Cells: Implications for Clinical Efficacy
    Matthieu Perreau, Franck Mennechet, Nicolas Serratrice +4
    Journal of VirologyPeer-reviewedLicence not stated58 citedGenetics & genomicsHAL
  4. Restoring dendritic cell migration: a gut reaction to boost vaccine efficacy in aging
    Liwei Zhao, Oliver Kepp, Guido Kroemer +1
    OncoImmunologyPeer-reviewedCC BYFull textImmunologyHAL
  5. Topology-Driven X-Shaped DNA as a cGAS Stimulator to Promote Dendritic Cell Activation and Antitumor Vaccine Efficacy.
    Jiabei Li, Xuan Wang, Dali Wei +5
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textImmunologyEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{melero20261115,
  title = {{1115 Cross-priming by type-1 conventional dendritic cells is critically involved in the efficacy of radiotherapy against cancer}},
  author = {Ignacio Melero and Arantza Azpilicueta and Maria Rodriguez-Ruiz and Alvaro Teijeira and David Sancho and Rafael MartÍNez-Monge and Leticia Fernández-Rubio and Raluca Alexandru and Irantzu Serrano-Mendioroz and Eneko Garate-Soraluze and Nekane Soria Picon and Paulo Perez-Dominguez and Carlos lury-Rey and Saioa Arrieta and Carlos E De Andrea},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1115},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1115},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1115 Cross-priming by type-1 conventional dendritic cells is critically involved in the efficacy of radiotherapy against cancer
AU  - Ignacio Melero
AU  - Arantza Azpilicueta
AU  - Maria Rodriguez-Ruiz
AU  - Alvaro Teijeira
AU  - David Sancho
AU  - Rafael MartÍNez-Monge
AU  - Leticia Fernández-Rubio
AU  - Raluca Alexandru
AU  - Irantzu Serrano-Mendioroz
AU  - Eneko Garate-Soraluze
AU  - Nekane Soria Picon
AU  - Paulo Perez-Dominguez
AU  - Carlos lury-Rey
AU  - Saioa Arrieta
AU  - Carlos E De Andrea
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1115
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1115
SN  - 2051-1426
ER  -